This report, curated by our Beacon Checkpoint experts, delves into both the drug and trial landscapes and spotlights the top five oncology indications. Inside these domains, you’ll uncover:
- A round-up of the top ten targets being studied
- An overview of the leading developers in both the clinical and preclinical settings and their assets
- An analysis of the progression of checkpoint trials over time and their phase distribution
- Insights into routes of administration, mechanisms of action, combination trials, and more!
To learn more about this report, or how Beacon Checkpoint can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.
Speak with our team of experts
Our dedicated account and research teams are on hand to showcase how Beacon can help you find the answers to your checkpoint-related questions
About Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
